Sandoz Company Profile

Aggregated data from the web about Sandoz

Company Name	Sandoz
Website	https://www.sandoz.com
Snippet	WebSandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people’s lives.
ISIN	CH0012005267
Type	Public (Aktiengesellschaft)
Founded	1996, (from merger)
Revenue	US$49.89 billion (2020)[3]
Website	Novartis.com
Founders	Johann RudolfAlexander Clavel
Industry	Pharmaceuticals
Products	Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)
Traded as	SIX: NOVN, NYSE: NVS
Key people	Vasant Narasimhan (CEO)[2]
Net income	US$8.07 billion (2020)[3]
Area served	Worldwide
Predecessor	Ciba-Geigy, Sandoz (via merger)
Headquarters	Basel, Switzerland (Global Commercial)Cambridge, Massachusetts,United States(Global research)[1]
Total assets	US$132.06 billion (2020)[3]
Total equity	US$56.67 billion (2020)[3]
Operating income	US$10.15 billion (2020)[3]
Number of employees	110,000 (2020)[3]

Sandoz is part of the Switzerland company list

Sandoz is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.